1. Home
  2. BRC vs ELVN Comparison

BRC vs ELVN Comparison

Compare BRC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

HOLD

Current Price

$84.66

Market Cap

4.1B

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

BUY

Current Price

$40.62

Market Cap

4.2B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BRC
ELVN
Founded
1914
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.2B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
BRC
ELVN
Price
$84.66
$40.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
14
Target Price
★ $110.00
$73.67
AVG Volume (30 Days)
207.9K
★ 1.2M
Earning Date
11-16-2026
11-11-2026
Dividend Yield
★ 1.19%
N/A
EPS Growth
N/A
★ 3.17
EPS
★ N/A
N/A
Revenue
★ $1,144,698,000.00
N/A
Revenue This Year
$74.03
N/A
Revenue Next Year
$3.84
N/A
P/E Ratio
$23.35
★ N/A
Revenue Growth
★ 5.86
N/A
52 Week Low
$70.57
$14.79
52 Week High
$99.29
$62.32

Technical Indicators

Market Signals
Indicator
BRC
ELVN
Relative Strength Index (RSI) 41.49 19.58
Support Level $83.52 $38.58
Resistance Level $86.99 $40.62
Average True Range (ATR) 1.92 1.92
MACD 0.39 -0.51
Stochastic Oscillator 58.33 11.05

Price Performance

Historical Comparison
BRC
ELVN

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: